September 12, 2012
SARASOTA, Fla. – Five years ago, 68-year-old Daniel Ferreira joined the one in six men who will be diagnosed with prostate cancer during their lifetime. Determined to be a survivor, Mr. Ferreira turned to one of Florida’s leading prostate cancer physicians, John Sylvester, M.D., a 21st Century Oncology physician practicing in Sarasota.
September 05, 2012
ABBEVILLE, Ala. – When 67-year-old Tallie Martin’s father died from prostate cancer, he made a decision to endeavor not to meet the same fate. Coming from a long line of cancer, the retired Alabama native and outdoor enthusiast knew his risk was high.
August 27, 2012
LAS VEGAS, Nev.—August 27, 2012—Saturday, September 29th, 2012 will mark the second annual This One’s for the Boys! Two-Mile Walk and Three-Mile Run to benefit 21st Century C.A.R.E. and the Las Vegas Chapter of Us TOO Prostate Cancer Support Group. The event will take place at 8:30 a.m. at the UNLV Track & Field Stadium. Registration for the event will be $25 online or $30 on the day of the event. The first 100 participants will receive an event t-shirt.
August 07, 2012
FORT MYERS, Fla.—August 7, 2012—21st Century Oncology, the nation’s premier cancer treatment network and largest radiation therapy provider, and Humana Inc. (NYSE: HUM) one of the nation’s leading health care and well-being companies, today announced a national agreement to enact case rate reimbursement for radiation therapy services.
July 09, 2012
July 09, 2012 (Las Vegas, Nev.)—21st Century Oncology – the nation’s premier cancer treatment network and largest radiation therapy provider – is expanding its group of oncology experts with the recent acquisition of Cancer Consultants, a well-established Las Vegas medical oncology and hematology practice. The union adds two new physicians dedicated in the delivery of compassionate care, further growing services in a community that currently includes multiple 21st Century Oncology radiation treatment centers spanning from Las Vegas to Henderson.
June 04, 2012
21st Century Oncology, the country’s largest radiation therapy provider and second largest urology group, responds to the U.S. Preventive Services Task Force (USPSTF) recommendations on the use of the prostate-specific antigen (PSA) test.
